Artelo Biosciences Inc. (ARTLW)
NASDAQ: ARTLW
· Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM
Artelo Biosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.61M | -1.78M | -2.29M | -3.48M | -2.39M | -2.47M | -1.95M | -2.55M | -1.89M | -2.25M | -1.87M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 2K | 544.00 | 636.00 | 253.00 |
Pretax Income | -2.45M | -1.6M | -2.17M | -3.34M | -2.33M | -2.45M | -1.97M | -2.55M | -1.89M | -2.25M | -1.87M |
Net Income | -2.45M | -1.6M | -2.04M | -3.2M | -2.26M | -2.43M | -1.98M | -2.55M | -1.89M | -2.25M | -1.87M |
Selling & General & Admin | 1.03M | 1.03M | 1.06M | 1.75M | 1.32M | 1.42M | 1.48M | 1.28M | 1.27M | 1.3M | 1.2M |
Research & Development | 1.58M | 752K | 1.24M | 1.73M | 1.08M | 1.06M | 464K | 1.27M | 615.46K | 951.2K | 663.36K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 62.00 |
Operating Expenses | 2.45M | 1.78M | 2.29M | 3.48M | 2.39M | 2.47M | 1.95M | 2.55M | 1.89M | 2.25M | 1.87M |
Interest Expense | n/a | n/a | n/a | n/a | 5K | n/a | 19K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.45M | 1.78M | 2.29M | 3.48M | 2.39M | 2.47M | 1.95M | 2.55M | 1.89M | 2.25M | 1.87M |
Income Tax Expense | 165K | n/a | -124K | -140K | -69K | -22K | 19K | -4K | -225 | -1.62K | -1.59K |
Shares Outstanding (Basic) | 2.95M | 2.86M | 2.86M | 2.83M | 2.85M | 2.83M | 2.82M | 2.03M | 30.44M | 1.54M | 1.13M |
Shares Outstanding (Diluted) | 2.95M | 2.86M | 2.86M | 2.83M | 2.85M | 2.83M | 2.82M | 2.03M | 30.44M | 1.54M | 1.13M |
EPS (Basic) | -0.83 | -0.56 | -0.72 | -1.13 | -0.79 | -0.86 | -0.7 | -1.26 | -0.06 | -1.46 | -1.65 |
EPS (Diluted) | -0.83 | -0.56 | -0.72 | -1.13 | -0.79 | -0.86 | -0.7 | -1.26 | -0.06 | -1.46 | -1.65 |
EBITDA | 165K | -1.97M | -2.42M | -3.48M | -2.39M | -2.49M | -1.93M | -2.56M | -1.89M | -2.25M | -1.87M |
EBIT | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 2.61M | -185K | -124K | -72K | 27.08K | -21K | 20K | 4K | 225.00 | 61.00 | 62.00 |